Danaher rises after quarterly profit beat
View all comments(0)
Life sciences firm Danaher's DHR.N shares rise 2.7% to $190 premarket
DHR posts Q1 adj. profit of $1.88 per share, beating analysts estimates of $1.64 per share, according to the data compiled by LSEG
Company posts Q1 revenue of $5.70 billion vs estimates of $5.59 billion
Company anticipates that Q2 revenue will grow low-single digits year-over-year
DHR expects annual profit in the range of $7.60 to $7.75 per share vs estimates of $7.68 per share
Company expects annual revenue to grow 3%
Company expects incurring incremental tariff costs in 2025 of several hundred millions of dollars
As of last close, DHR fell 19.4% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

'Big Short' Burry Doubles Down: Nvidia, Palantir Short Positions Double in Big Bet on AI Bubble Bursting

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Tradingkey








Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.